ETFs positioned on Sun Pharmaceutical Industries Ltd.

Logo Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Employees
43,000
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
1,786.40INR
Average target price
2,039.91INR
Spread / Average Target
+14.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SUNPHARMA Stock
  4. ETFs Sun Pharmaceutical Industries Ltd.
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!